Transcript THOMSON REUTERS PRESENTATION TEMPLATE

Thomson Reuters – Future of Databases
Academic & Government Markets
Erik-Jan Van-Kleef
Director of Sales EMEA
September 2008
Scientific Innovation
First online
research Derwent online
service
Science
Citation Index
1960
1965
Dialog online
information
retrieval
1970
1975
World Patents
Index
1980
1985
GENESEQ
IDRAC
Delphion
Thomson
Pharma
1990
1995
2000
2005
MicroPatent
Techstreet
Web of Science
MDC
2007
Century of
Science
ISI Web of
Knowledge
Newport
Horizon
Manuscript
Management
Toolset
2
Current Strategic Position
A&G solutions are increasingly being tailored to address the scholarly research
workflow and drive growth
Major Applications
Discovery
 Find and validate relevant
scientific content
Publishing,
Authoring and
Collaboration
 Identify specialists and
collaborators
 Leverage manuscript formatting
 Expose evolving research
 Manage ePeer review
 Identify authors and institutions
uniquely
 Simplify collaborative authoring
Performance
Evaluation
 Benchmark performance
across peer researchers,
departments, and institutions
 Custom analysis of trends and
impact
Core Solutions
Web of Knowledge
Manuscript Central
Research Services
EndNote, EndNote Web
Essential Science Indicators
Key Customers
• Scientists, Researchers, Scholars
• Authors, Patent Applicants
• Librarians, Information Professionals
• Publishers, Editors, Reviewers
• Provost, Minister of Education, Administrator
• Publishers, Editors
• Scientists, Researchers, Scholars
Market Leadership
• Web of Knowledge serves over
3,700 institutions worldwide
• 5 of 6 top publishers rely on
Manuscript Central
• 12 products now integrated on
Web of Knowledge
• EndNote is #1 reference software in
scholarly writing and publishing
Core Products
• All STM publishers monitor their journal
Impact Factor
• Governments rely on custom research
services to manage research policy
A&G Market Leadership
Web of Knowledge
Web of Science
Web of Knowledge used
by over 20 million
researchers worldwide
Core content includes
Web of Science, Biosis,
and partner resources
Web of Science - double
digit growth for 9
consecutive years
49% penetration rate
target market
Over 58% increase in
Web of Knowledge usage
in 2007
Global presence – up
from 50 countries in 2003
to 84 by 2007
Analytical tools,
publishing software &
services and links with
customer content
Introducing regional
Chinese citation index
and localized UI
EndNote
Manuscript Central
EndNote - #1 reference
software in scholarly
writing and publishing
Strong integration with
Web of Science, MS
Word and Manuscript
Central
Manuscript Central –
delivers e-peer review
solution to publishers
Configurable software-asservice solution adapts to
client workflows
Over 2 million cumulative
units sold
EndNote Web extends
reach to undergrad and
mobile researchers
5 of 6 top publishers rely
on Manuscript Central
Reduces time to
publication from months
to weeks
The ISI Web of Knowledge is anchored by Thomson Scientific premium
core content, complemented by carefully selected partner content, and
supported by powerful tools
Selected Partner Content:
Thomson Scientific
Premium Content
•INSPEC
•CAB Abstracts
•Food Science & Technology
Abstracts
Bibliographic Resources:
Journal Literature:
•MEDLINE
•Web of Science (SCI, SSCI,
AHCI)
•Current Contents Connect
Analytic Resources
•BIOSIS Previews & Biological
Abstracts
• Journal Citation Reports
Bibliographic Tools
•Zoological Record
• EndNote
Patents:
• Reference Manager
•Derwent Innovations Index
Conferences/Proceedings:
•ISI Proceedings
• Essential Science Indicators
• Research Evaluation
Reources
• Citation Reports
• Science Indicators
The Current State
Total Customers – nearly 4,000 in over 80 countries
• With over 3,900 institution customers, significant customer growth in all markets
• Strongest growth in international markets, from business in 50 countries (2003) to
84 countries (end of 2007)
• 54% of business outside North America
2003-2007
650+ customers
1500+ customers
250+ customers
“Life Sciences” Research
– the Present and Future…
Within the vast realm of the Life Sciences or “biomedical
research” there is today extreme emphasis on integration of
fundamental discovery and its application in clinical medicine –
translational science-research-medicine.
 This collaborative, interdisciplinary approach among traditional
“researchers” and clinicians presents new requirements for supporting
informational resources.
 What is needed is a diverse collection of integrated content delivered
within a set of tools and features capable of driving fundamental discovery
as well as supporting the decision-making process for clinicians and
researchers alike.
“Life Sciences” Research
– the Present and Future…
Therefore – Thomson Reuters now presents a diverse collection
of integrated knowledge-bases in order to serve the molecular
biologists, immunologists, pharmacologists, etc. in the lab as well
as the oncologists, cardiologists, neurologists, etc. in the clinic.
Biomarkers
Genomics
Adverse Events
Molecular
Therapeutic
Targets
Pharmacokinetics
Drugs and
Bioactive
Compounds
Clinical
Studies
Experimental
Pharmacology
“Life Sciences” Research
– the Present and Future… true integration for translational
research
These knowledge-bases draw from a wide range of sources, are
supported by Thomson Reuters experts as well as an international
contributor network, and are complemented by additional content
such as disease briefings and bioinformatics resources.
Published
Research
Conference
and Symposia
Presentations
Biomarkers
Genomics
Bioinformatics
Resources
Intellectual
Property
Adverse Events
Molecular
Therapeutic
Targets
Regulatory
Information
Pharmacokinetics
Drugs and
Bioactive
Compounds
Clinical
Guidelines
Clinical
Studies
Experimental
Pharmacology
Disease
Briefings
Investigator Portal from Thomson
Reuters is the resource to
optimize workflow in the
translational research
environment.
It is the source of the vast majority
of content we’ve just presented .
Designed to meet the challenges
of interdisciplinary biomedical
research.
Integration is the key, and
Investigator Portal is designed to
link all related information among its
knowledge bases.
Here for example – this particular
result of a search on “Alzheimer”
within Therapeutic Targets and
Pathways links to related
In fact, for any search results in any
knowledge base Investigator Portal
reveals related information within all
other knowledge bases.
The landscape is quickly identified
and related info accessible.
For Academic Researchers in Large Research
Institutes
• Thomson Pharma is a comprehensive global
pharmaceutical information solution
• Thomson Pharma covers the entire drug discovery and
development pipeline
Discover
Develop
Launch
Innovate
• Academic institutions are not in the business of making
new drugs, but licensing their research findings and
working with Large Pharma
Patent Data
Thomson Pharma integrates content
from over 40 resources
Commercial Data
Content
Integration
Chemistry Data
Literature &
News Data
Drug Data
Target Data
Gene Sequence Data
Content:
Formatted into relevant Reports
Content is divided up into 10
concatenated “living” reports derived from over 40 resources
“Living Records”
Sales and Market share
information available for drugs
with actual or forecasted sales
of $100 million/year (between
2006-2010).
You can see by the graph there is more
competition in the area of diabetes in 2008
Licensing details – who
owns the rights to the drug
Potential Usage for Academics
• Researchers focused on Drug Discovery or Licensing
Technology
– Chemistry Report, Target Report etc.
– Integrated content from multiple sources provide
instantaneous overviews of any topic
– Unique business data
• Research Planning / Funding
– Make the most effective return on research investment
– Don't waste resources on topics that already have a lot of
research investment by the pharma industry
– Identify sources of research funding and collaboration
“Life Sciences” Research
– the Present and Future…
There is another “layer” of information that is extremely
important to those operating within the research
environment.
Biomedical research today is, for most, a results-driven,
competitive, and overall pressure-filled environment.
Foresight with regard to planning the future direction of
research activities, and the right people to support these
activities, is invaluable.
Thomson Scientific
Introducing the Thomson Collexis Dashboard
Providing enhanced knowledge discovery for the
academic and government R&D communities.
The Thomson Collexis Dashboard is a text mining
tool to analyze topic areas such as diseases or
drugs, providing expert profiles, trend information
and powerful knowledge discovery.
By merging Thomson Scientific’s Web of Science
data with the Collexis Knowledge Dashboard,
users will have the ability to identify and search for
documents, experts and trends, and make new
discoveries more quickly, accurately and deeply
than via conventional search engines.
Thomson Scientific
Exploring by Concept is a
fundamental benefit of the
Knowledge dashboard.
Here we select Alzheimer Disease
as defined by MeSH, and then
Neurofibrillary Tangles as a subset.
Thomson Scientific
The body of papers within the
Neurofibrillary Tangles area is
presented.
This information can be
explored in a variety of ways --
the selection of “Experts”
presents top researchers within
this realm.
Thomson Scientific
“Locations” provides a
geographic overview, where
Links to the full records in
Web of Science are presented.
research is being produced.
Thomson Scientific
Collexis data mining
technology identifies hidden
relationships, predicting
future areas of study within
“Alzheimer’s Research”.
Thomson Scientific
Information on particular
Researchers may be retrieved.
Identify “Experts through Experts”
– co-authors are revealed,
including active and most prolific.
“Life Sciences” Research
– the Present and Future… true content integration to
meet the workflow needs of Life Sciences Researchers
Thomson
Collexis
Dashboard
Thomson Reuters Life Sciences
Resources
Supporting and Driving Discovery, Development, and
Clinical Treatment